Live from the NIH registry
Studies recruiting near Huntington right now
Top 25 of 55 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC)
Phase 3
Interventional 276 participants sought
University Physicians and Surgeons Inc, dba Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: Ipsen
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Neoplasms, Arteriovenous Malformation of Central Nervous System
N/A
Observational 50,000 participants sought
St. Mary's Medical Center — Huntington, West Virginia (0.8 mi)
· Sponsor: The Radiosurgery Society
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
Huntington VA Medical Center, Huntington, WV — Huntington, West Virginia (0.8 mi)
· Sponsor: VA Office of Research and Development
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Glioblastoma, IDH-Wildtype
Phase 2
Interventional 100 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension
N/A
Observational 900 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: United Therapeutics
Responding With Evidence and Access for Childhood Headaches
Headache, Headache Disorders
N/A
Interventional 400 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Wake Forest University Health Sciences
IBS Skin Patch Test Food Allergy Study
Irritable Bowel Syndrome
N/A
Interventional 250 participants sought
Shepherd Allergy — Barboursville, West Virginia (7.6 mi)
· Sponsor: IBS-80, LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Huntington, West Virginia (0.8 mi)
· Sponsor: Sameek Roychowdhury
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8
Phase 3
Interventional 304 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Migraine Disorders
Phase 4
Interventional 132 participants sought
Upsher-Smith Clinical Trial Site #9 — Huntington, West Virginia (0.8 mi)
· Sponsor: Upsher-Smith Laboratories
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Opioid Use Disorder, Opioid Use Disorder, Moderate
Phase 2
Interventional 310 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: T. John Winhusen, PhD
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
Marshall University Joan C. Edwards School of Medicine — Huntington, West Virginia (0.8 mi)
· Sponsor: LivaNova
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Oncology Group
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: SWOG Cancer Research Network
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Cabell Huntington Hospital — Huntington, West Virginia (0.8 mi)
· Sponsor: Stryker Instruments
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Oncology Group
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention
Lung Cancer Screening
N/A
Interventional 35,500 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi)
· Sponsor: Timothy Mullett
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology